The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Open accessAbstract
Drug combinations are a promising strategy to overcome the compensatory mechanisms and unwanted off-target effects that limit the utility of many potential drugs. However, enthusiasm for this approach is tempered by concerns that the therapeutic synergy of a combination will be accompanied by synergistic side effects. Using large scale simulations of bacterial metabolism and 94,110 multi-dose experiments relevant to diverse diseases, we provide evidence that synergistic drug combinations are generally more specific to particular cellular contexts than are single agent activities. We highlight six combinations whose selective synergy depends on multitarget drug activity. For one anti-inflammatory example, we show how such selectivity is achieved through differential expression of the drugs' targets in cell types associated with therapeutic, but not toxic, effects and validate its therapeutic relevance in a rat model of asthma. The context specificity of synergistic combinations creates many opportunities for therapeutically relevant selectivity and enables improved control of complex biological systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Numerical recipes in C: the art of scientific computing
(1993) · Choice Reviews Online · doi:10.5860/choice.30-5638 · Cited by 17,933
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Global Mapping of the Yeast Genetic Interaction Network
Tong, A. H. Y., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., et al. (2004) · Science · doi:10.1126/science.1091317 · Cited by 2,095
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Numerical Recipes in C-The Art of Scientific Computing.
G., W., Press, W. H., Flannery, B. P., Teukolsky, S. A., & Vetterling, W. T. (1989) · Mathematics of Computation · doi:10.2307/2008673 · Cited by 1,513
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Amiloride and its analogs as tools in the study of ion transport
Kleyman, T. R., & Cragoe, E. J. (1988) · The Journal of Membrane Biology · doi:10.1007/bf01871102 · Cited by 1,140
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Self-citationRobustness of cellular functions
Stelling, J., Sauer, U., Szallasi, Z., Doyle, F. J., & Doyle, J. (2004) · Cell · doi:10.1016/j.cell.2004.09.008 · Cited by 1,049
Edwards, J. S., Ibarra, R. U., & Palsson, B. O. (2001) · Nature Biotechnology · doi:10.1038/84379 · Cited by 939
Principles for the buffering of genetic variation
Hartman, J. L., Garvik, B., & Hartwell, L. (2001) · Science · doi:10.1126/science.1056072 · Cited by 808
Principles for the Buffering of Genetic Variation
Hartman IV, J. L. (2001) · Science · doi:10.1126/science.291.5506.1001 · Cited by 808
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Self-citationExploring genetic interactions and networks with yeast
Boone, C., Bussey, H., & Andrews, B. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2085 · Cited by 661
Duarte, N. C., Herrgård, M. J., & Palsson, B. Ø. (2004) · Genome Research · doi:10.1101/gr.2250904 · Cited by 639
Systematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620
Self-citationModular epistasis in yeast metabolism
Segrè, D., DeLuna, A., Church, G. M., & Kishony, R. (2005) · Nature Genetics · doi:10.1038/ng1489 · Cited by 575
The expected effect of a combination of agents: the general solution
Berenbaum, M. C. (1985) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(85)80176-4 · Cited by 523
A robustness-based approach to systems-oriented drug design
Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
Apsel, B., Blair, J. A., Gonzalez, B., Nazif, T. M., Feldman, M. E., Aizenstein, B., Hoffman, R., Williams, R. L., Shokat, K. M., & Knight, Z. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.117 · Cited by 440
Synthetic Biology for Synthetic Chemistry
Keasling, J. D. (2008) · ACS Chemical Biology · doi:10.1021/cb7002434 · Cited by 409
Functional classification of drugs by properties of their pairwise interactions
Yeh, P., Tschumi, A. I., & Kishony, R. (2006) · Nature Genetics · doi:10.1038/ng1755 · Cited by 350
Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions
Onge, R. P. S., Mani, R., Oh, J., Proctor, M., Fung, E., Davis, R. W., Nislow, C., Roth, F. P., & Giaever, G. (2007) · Nature Genetics · doi:10.1038/ng1948 · Cited by 309
Chemical combination effects predict connectivity in biological systems
Lehár, J., Zimmermann, G. R., Krueger, A. S., Molnar, R. A., Ledell, J. T., Heilbut, A. M., Short, G. F., Giusti, L. C., Nolan, G. P., Magid, O. A., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100116 · Cited by 275
Self-citationMetabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions
Edwards, J. S., & Palsson, B. O. (2000) · BMC Bioinformatics · doi:10.1186/1471-2105-1-1 · Cited by 268
Drug-eluting stents: caution and concerns for long-term outcome
Virmani, R., Farb, A., Guagliumi, G., & Kolodgie, F. D. (2004) · Coronary Artery Disease · doi:10.1097/00019501-200409000-00003 · Cited by 231
Die quantitativen Probleme der Pharmakologie
Loewe, S. (1928) · Ergebnisse der Physiologie · doi:10.1007/bf02322290 · Cited by 229
An integrated platform of genomic assays reveals small-molecule bioactivities
Hoon, S., M Smith, A., Wallace, I. M., Suresh, S., Miranda, M., Fung, E., Proctor, M., Shokat, K. M., Zhang, C., Davis, R. W., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.100 · Cited by 201
Finding multiple target optimal intervention in disease‐related molecular network
Yang, K., Bai, H., Ouyang, Q., Lai, L., & Tang, C. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.60 · Cited by 186
Evolutionary plasticity of genetic interaction networks
Tischler, J., Lehner, B., & Fraser, A. G. (2008) · Nature Genetics · doi:10.1038/ng.114 · Cited by 131
From large networks to small molecules
Sharom, J. R., Bellows, D. S., & Tyers, M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.12.007 · Cited by 103
High‐order combination effects and biological robustness
Lehár, J., Krueger, A., Zimmermann, G. R., & Borisy, A. A. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.51 · Cited by 101
Self-citationA mathematical model of combination therapy using the EGFR signaling network
Araujo, R. P., Petricoin, E. F., & Liotta, L. A. (2004) · Biosystems · doi:10.1016/j.biosystems.2004.10.002 · Cited by 93
Salicru, A. N., Sams, C., & Marshall, G. D. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.02.006 · Cited by 93
Kassouf, W., Dinney, C. P., Brown, G. A., McConkey, D. J., Diehl, J. A., Bar‐Eli, M., & Adam, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1536 · Cited by 92
2007 FDA drug approvals: a year of flux
Hughes, B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2514 · Cited by 92
Zarraga, I. G. E., & Schwarz, E. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.003 · Cited by 82
Okamoto, M., Ōno, M., & Baba, M. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.1239 · Cited by 74
Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis
Kvien, T. K., Fjeld, E., Slatkowsky-Christensen, B., Nichols, M., Zhang, Y., Prøven, A., Mikkelsen, K., Palm, Ø., Borisy, A. A., & Lessem, J. N. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074401 · Cited by 70
Self-citationZimmermann, G. R., Avery, W., Finelli, A. L., Farwell, M., Fraser, C. C., & Borisy, A. A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2602 · Cited by 55
Self-citationDissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index.
Schäcke, H., Rehwinkel, H., & Asadullah, K. (2005) · PubMed · Cited by 50
Radhakrishnan, M. L., & Tidor, B. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700452r · Cited by 33
How and When Should Combination Therapy be Used? the Role of an Anchor Drug
Farr, M., & Bacon, P. A. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/xxxiv.suppl_2.100 · Cited by 15
Cited by
Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393
Photopharmacology: Beyond Proof of Principle
Velema, W. A., Szymanski, W., & Feringa, B. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja413063e · Cited by 1,178
Analysis of drug combinations: current methodological landscape
Foucquier, J., & Guedj, M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.149 · Cited by 1,115
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
Yadav, B., Wennerberg, K., Aittokallio, T., & Tang, J. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.09.001 · Cited by 845
“…example, aneffective drugcombination maytarget multiple proteinsor pathways that are aberrantly activated in disease, but not in normal cells, and thus reduces the chances that a cancer will develop drug resistance by activating bypassing pathways, when compared to standard mono-therapies [1 – 3].”
Metadata
- Authors
- Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., Lee, M. S., Zimmermann, G. R., & Borisy, A. A.
- Venue
- Nature Biotechnology
- Published
- 2009-07
- Volume
- 27
- Issue
- 7
- Pages
- 659-666
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2044025814
- Cited by
- 938
- References
- 49
- FWCI
- 27.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.